These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11402938)

  • 1. [Acute respiratory distress syndrome after antineoplastic chemotherapy. Probable role of gemcitabine].
    de Lavigerie B; Joasson JM
    Presse Med; 2001 May 5-12; 30(17):851-4. PubMed ID: 11402938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable outcome of gemcitabine-induced respiratory distress syndrome.
    Girard T; Mouthon L; Boaziz C; Andre MH; Guillevin L
    Ann Med Interne (Paris); 2000 Jun; 151(4):306-8. PubMed ID: 10922960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Favorable outcome of gemcitabine-induced acute respiratory distress syndrome].
    Bonnichon A; Vedrine L; Aletti M; Le Moulec S; Borne M; Margery J; Bauduceau O; Fayolle M; Ceccaldi B
    Rev Pneumol Clin; 2007 Dec; 63(6):379-83. PubMed ID: 18166944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interstitial lung disease in a patient given gemcitabine].
    Hammerer V; Schmitz N; Pauli G; Quoix E
    Rev Pneumol Clin; 2002 Feb; 58(1):23-6. PubMed ID: 11981501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autopsy case of acute pulmonary toxicity associated with gemcitabine.
    Maniwa K; Tanaka E; Inoue T; Kato T; Sakuramoto M; Minakuchi M; Maeda Y; Noma S; Kobashi Y; Taguchi Y
    Intern Med; 2003 Oct; 42(10):1022-5. PubMed ID: 14606719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation myositis: the possible role of gemcitabine.
    Ganem G; Solal-Celigny P; Joffroy A; Tassy D; Delpon A; Dupuis O
    Ann Oncol; 2000 Dec; 11(12):1615-6. PubMed ID: 11205473
    [No Abstract]   [Full Text] [Related]  

  • 8. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
    Gagel B; Piroth M; Pinkawa M; Reinartz P; Zimny M; Fischedik K; Stanzel S; Breuer C; Skobel E; Asadpour B; Schmachtenberg A; Buell U; Eble MJ
    Strahlenther Onkol; 2006 May; 182(5):263-9. PubMed ID: 16673059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden cardio-pulmonary toxicity following a single infusion of gemcitabine.
    Ciotti R; Belotti G; Facchi E; Cantù A; D'Amico A; Gatti C
    Ann Oncol; 1999 Aug; 10(8):997. PubMed ID: 10509166
    [No Abstract]   [Full Text] [Related]  

  • 11. Gemcitabine-induced radiation necrosis of the pectoralis major muscle.
    Horan G; Smith SL; Podd TJ
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):85. PubMed ID: 16477926
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
    Pavlakis N; Bell DR; Millward MJ; Levi JA
    Cancer; 1997 Jul; 80(2):286-91. PubMed ID: 9217042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine-induced respiratory failure associated with elevated erythrocyte sedimentation rate (ESR).
    Davidoff S; Shah RD; Arunabh T
    Respir Med; 2006 Apr; 100(4):760-3. PubMed ID: 16199150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II study.
    Zatloukal P; Kanitz E; Magyar P; Jassem J; Krzakowski M; Pawlicki M; Petruzelka L; Chovan L; Pesek M; Janko C; Krejcy K
    Lung Cancer; 1998 Dec; 22(3):243-50. PubMed ID: 10048477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer.
    Sørensen JB; Bergman B; Nielsen AL; Krarup M; Dombernowsky P; Hansen HH
    Br J Cancer; 1999 Feb; 79(5-6):875-81. PubMed ID: 10070884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Asbestos--gemcitabin. Combined risk for pulmonary toxicity?].
    Camus P
    Rev Mal Respir; 2003 Apr; 20(2 Pt 1):187-9. PubMed ID: 12844015
    [No Abstract]   [Full Text] [Related]  

  • 17. A phase II study of single-agent gemcitabine as a second-line treatment in advanced non-small cell lung cancer.
    Cho KH; Song YB; Choi IS; Cho EH; Choi JW; Ahn YM; Roh YH; Nam SH; Kim BS
    Jpn J Clin Oncol; 2006 Jan; 36(1):50-4. PubMed ID: 16418187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of squamous cell carcinoma of the pancreas with gemcitabine].
    Bideau K; Metges JP; Bayle S; André M; Robaszkiewicz M; Lagarde N; Labat JP
    Gastroenterol Clin Biol; 2006 Oct; 30(10):1217-20. PubMed ID: 17075482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
    Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
    Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.